Clinical Trial Update: Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity and safety of the HPV vaccine in solid organ transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complication From Kidney Transplant
• Complication of Transplanted Liver
• Human Papillomavirus-related Carcinoma

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Late Complication From Kidney Transplant, Complication of Transplanted Liver | Phase 4 | Status: COMPLETED